Literature DB >> 28626064

Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse.

Katharina M Quell1, Christian M Karsten1, Anna Kordowski1, Larissa Nogueira Almeida1, Daria Briukhovetska1, Anna V Wiese1, Jing Sun1, Fanny Ender1, Konstantina Antoniou1, Torsten Schröder1, Inken Schmudde2, Johann L Berger2, Peter König2, Tillman Vollbrandt3, Yves Laumonnier4, Jörg Köhl4,5.   

Abstract

C3a exerts multiple biologic functions through activation of its cognate C3a receptor. C3-/- and C3aR-/- mice have been instrumental in defining important roles of the C3a/C3aR axis in the regulation of acute and chronic inflammatory diseases, including ischemia/reperfusion injury, allergic asthma, autoimmune nephritis, and rheumatoid arthritis. Surprisingly little is known about C3aR expression and function in immune and stromal cells. To close this gap, we generated a floxed tandem-dye Tomato (tdTomato)-C3aR reporter knock-in mouse, which we used to monitor C3aR expression in cells residing in the lung, airways, lamina propria (LP) of the small intestine, brain, visceral adipose tissue, bone marrow (BM), spleen, and the circulation. We found a strong expression of tdTomato-C3aR in the brain, lung, LP, and visceral adipose tissue, whereas it was minor in the spleen, blood, BM, and the airways. Most macrophage and eosinophil populations were tdTomato-C3aR+ Interestingly, most tissue eosinophils and some macrophage populations expressed C3aR intracellularly. BM-derived dendritic cells (DCs), lung-resident cluster of differentiation (CD) 11b+ conventional DCs (cDCs) and monocyte-derived DCs, LP CD103+, and CD11b+ cDCs but not pulmonary CD103+ cDCs and splenic DCs were tdTomato-C3aR+ Surprisingly, neither BM, blood, lung neutrophils, nor mast cells expressed C3aR. Similarly, all lymphoid-derived cells were tdTomato-C3aR-, except some LP-derived type 3 innate lymphoid cells. Pulmonary and LP-derived epithelial cells expressed at best minor levels of C3aR. In summary, we provide novel insights into the expression pattern of C3aR in mice. The floxed C3aR knock-in mouse will help to reliably track and conditionally delete C3aR expression in experimental models of inflammation.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28626064     DOI: 10.4049/jimmunol.1700318

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  C3a elicits unique migratory responses in immature low-density neutrophils.

Authors:  Brian E Hsu; Joannie Roy; Jack Mouhanna; Roni F Rayes; LeeAnn Ramsay; Sébastien Tabariès; Matthew G Annis; Ian R Watson; Jonathan D Spicer; Santiago Costantino; Peter M Siegel
Journal:  Oncogene       Date:  2020-02-04       Impact factor: 9.867

2.  Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer's Disease.

Authors:  Alexandra Litvinchuk; Ying-Wooi Wan; Dan B Swartzlander; Fading Chen; Allysa Cole; Nicholas E Propson; Qian Wang; Bin Zhang; Zhandong Liu; Hui Zheng
Journal:  Neuron       Date:  2018-11-08       Impact factor: 17.173

3.  Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2.

Authors:  Faith H Brennan; Trisha Jogia; Ellen R Gillespie; Linda V Blomster; Xaria X Li; Bianca Nowlan; Gail M Williams; Esther Jacobson; Geoff W Osborne; Frederic A Meunier; Stephen M Taylor; Kate E Campbell; Kelli Pa MacDonald; Jean-Pierre Levesque; Trent M Woodruff; Marc J Ruitenberg
Journal:  JCI Insight       Date:  2019-05-02

Review 4.  Complement and the Regulation of T Cell Responses.

Authors:  Erin E West; Martin Kolev; Claudia Kemper
Journal:  Annu Rev Immunol       Date:  2018-04-26       Impact factor: 28.527

Review 5.  Complement-Mediated Events in Alzheimer's Disease: Mechanisms and Potential Therapeutic Targets.

Authors:  Andrea J Tenner
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

6.  Sialic acid is a critical fetal defense against maternal complement attack.

Authors:  Markus Abeln; Iris Albers; Ulrike Peters-Bernard; Kerstin Flächsig-Schulz; Elina Kats; Andreas Kispert; Stephen Tomlinson; Rita Gerardy-Schahn; Anja Münster-Kühnel; Birgit Weinhold
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

7.  Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging.

Authors:  Nicholas E Propson; Ethan R Roy; Alexandra Litvinchuk; Jörg Köhl; Hui Zheng
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 8.  New insights into the immune functions of complement.

Authors:  Edimara S Reis; Dimitrios C Mastellos; George Hajishengallis; John D Lambris
Journal:  Nat Rev Immunol       Date:  2019-08       Impact factor: 53.106

Review 9.  Complement and human T cell metabolism: Location, location, location.

Authors:  Erin E West; Natalia Kunz; Claudia Kemper
Journal:  Immunol Rev       Date:  2020-03-12       Impact factor: 10.983

10.  The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells.

Authors:  Anna V Wiese; Fanny Ender; Katharina M Quell; Konstantina Antoniou; Tillman Vollbrandt; Peter König; Jörg Köhl; Yves Laumonnier
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.